Skip to main content
Cantourage Group SE logo

Cantourage Group SE — Investor Relations & Filings

Ticker · HIGH ISIN · DE000A3DSV01 LEI · 3912003NCTLO6YHA9V48 XMIL Manufacturing
Open in API
Filings indexed 109 across all filing types
Latest filing 2023-10-25 Investor Presentation
Country DE Germany
Listing XMIL HIGH

About Cantourage Group SE

https://www.cantourage.com/

Cantourage Group SE is a company specializing in the production and distribution of medical cannabis. It operates a platform that enables global cultivators to access the European market by managing the import, processing, and distribution of cannabis products. The company processes raw materials from its international partners into EU-compliant finished medicinal products, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Its portfolio features a diverse range of cannabis strains. Additionally, Cantourage operates the 'Telecan' telemedicine platform to facilitate patient access to cannabis-based therapies. The company's strategy involves developing new cannabis medicines and working to lower the cost of treatment for patients.

Recent filings

Filing Released Lang Actions
Cantourage Group SE: NuWays confirms 'Buy' recommendation
Investor Presentation Classification · 99% confidence The document is a short news release (3875 characters) disseminated via EQS News. The core content announces that the research house NuWays AG confirmed a 'Buy' recommendation and set a price target for Cantourage Group SE shares. This type of announcement, which relays external analyst research or general market commentary rather than official company financial results (ER, IR, 10-K) or mandatory regulatory filings, typically falls under general regulatory news or investor relations updates. Since it is not a specific mandatory filing like a Director's Dealing (DIRS) or a Dividend Notice (DIV), and it is an announcement about external research rather than a formal company report, the most appropriate classification is Regulatory Filings (RNS) as a general news dissemination, or potentially Investor Presentation (IP) if it were a company-produced deck, but here it is an external analyst update being published as news. Given the context of EQS News dissemination for non-core mandatory reports, RNS is the best fit as a general regulatory/news announcement.
2023-10-25 English
Cantourage Group SE launches a range of high-THC medicinal cannabis flowers in Switzerland together with Astrasana
Regulatory Filings Classification · 95% confidence The document is a press release disseminated via EQS News, announcing a business development: Cantourage Group SE launching high-THC medicinal cannabis flowers in Switzerland through a partnership with Astrasana. It contains market launch keywords, partnership details, and company descriptions, but it is not a formal financial report (like 10-K or IR), an earnings release (ER), or a proxy statement. It is a general corporate announcement regarding market expansion and commercial activity. Since it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), and it is a news announcement rather than a detailed report, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for general corporate news releases that aren't covered by more specific codes.
2023-10-24 English
Montega AG includes Cantourage Group SE in its coverage with 'Buy'
Regulatory Filings Classification · 100% confidence The document is a short news release dated October 20, 2023, announcing that the research house Montega AG initiated coverage on Cantourage Group SE with a 'Buy' recommendation and a specific price target. This is not a full financial report (like 10-K or IR), nor is it a formal regulatory filing like a Director's Dealing or Major Shareholding Notification. It is an announcement about external research coverage. Since it doesn't fit the specific categories like ER, CT, or DIV, and it is a general corporate news item disseminated via EQS News, the most appropriate classification is the general regulatory/news fallback category, RNS (Regulatory Filings), as it is a standard corporate announcement that doesn't map to a more specific financial disclosure type.
2023-10-20 English
Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awards 2023
Regulatory Filings Classification · 100% confidence The document is a news release disseminated via EQS-News, dated September 25, 2023. The content announces that Cantourage Group SE has been shortlisted for the European Small and Mid-Cap Awards 2023 in the 'Star of Innovation' category. This is a general corporate announcement regarding an award nomination, not a mandatory financial filing like a 10-K, an earnings release (ER), or a specific regulatory report (AR, IR, etc.). Since it is a general corporate news item that doesn't fit the highly specific categories (like DIV, DIRS, CAP, etc.), the most appropriate classification is the general regulatory/news fallback category, RNS (Regulatory Filings), as it is a formal announcement distributed through a news service.
2023-09-25 English
Telecan: Germanys largest medical cannabis company launches online platform for cannabis on prescription
Regulatory Filings Classification · 100% confidence The document is a news release announcing the launch of a new telemedicine platform called Telecan° by Cantourage Group SE. It uses the standard format for corporate news dissemination, referencing 'EQS-News' and providing company details, date, and contact information. This type of announcement, detailing a new business initiative or service launch, is generally classified as a general corporate announcement. Since it is not a formal financial report (like 10-K or IR), an earnings release (ER), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate general category for a corporate news item that doesn't fit elsewhere is Regulatory Filings (RNS), which often serves as a catch-all for significant, non-standardized corporate news releases distributed via official channels like EQS.
2023-09-01 English
Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology
M&A Activity Classification · 99% confidence The document is a news release disseminated via EQS-News, dated August 10, 2023, announcing a new partnership between Cantourage Group SE and SUMO Cannabis regarding the supply of medicinal cannabis. It contains standard press release formatting, including disclaimers ('Not for release or distribution...'), company descriptions, and contact information. This type of announcement, which is a general corporate update about a business development (a partnership), does not fit the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, CAP, DIRS). Since it is a general corporate news item distributed via a regulatory news service (EQS), and it is not a formal regulatory filing like a 10-K or a specific report like an AR or IP, the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements that don't fit elsewhere, especially when distributed through such channels.
2023-08-10 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.